Announcements Trials
Browse Landscape

Phase

Phase 2 17Phase 1 10Phase 1/2 6Phase NA 2Phase 3 2Phase 4 1

Status

Recruiting 1Not yet recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

CNS 2Sarcoma 1Other hematologic neoplasm 1Lymphoid 1

Conditions

Breast Neoplasms 387Neoplasms 333Prostatic Neoplasms 188Lung Neoplasms 175Colorectal Neoplasms 142Motor Activity 87Pancreatic Neoplasms 73Uterine Cervical Neoplasms 70Brain Neoplasms 69Head and Neck Neoplasms 67Carcinoma, Non-Small-Cell Lung 63Ovarian Neoplasms 59Rectal Neoplasms 49Carcinoma, Hepatocellular 49Colonic Neoplasms 46Glioblastoma 42Anxiety Disorders 41Precursor Cell Lymphoblastic Leukemia-Lymphoma 39Depression 39Neoplasm Metastasis 38Hematologic Neoplasms 37Melanoma 34Glioma 34Multiple Myeloma 33Disease 33Stomach Neoplasms 32Sarcoma 31Carcinoma, Renal Cell 30Urinary Bladder Neoplasms 29Pain 28

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase NA × Medulloblastoma × 90 days × Clear all
NCT05057702 2026-04-15

PNOC027

University of California, San Francisco

Phase NA Recruiting
74 enrolled
CNS

Ependymoma, Medulloblastoma

NCT07516353 2026-04-08

my.naviGATE: A Guide to After-Treatment Effects for Adolescents and Young Adults

Dana-Farber Cancer Institute

Phase NA Not yet recruiting
143 enrolled
CNSLymphoidOther hematologic neoplasmSarcoma

Medulloblastoma, Rhabdomyosarcoma, Sarcoma, Sarcoma, Ewing, Osteosarcoma, Leukemia, Myeloid, Acute, Precursor Cell Lymphoblastic Leukemia-Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡